Is targeted therapy or immunotherapy better for gallbladder cancer?
The treatment of gallbladder cancer cannot be judged as whether targeted therapy or immunotherapy is better, but should be analyzed based on the specific condition of the disease.
For early-stage gallbladder cancer patients, if no metastasis has occurred, the best treatment at this time is primarily surgical removal. Early-stage surgical removal can achieve a cure, and regular postoperative ultrasound checks to monitor the disease progression are sufficient.
However, if the gallbladder cancer progresses to a late stage, there might be metastasis to other parts of the body, corresponding symptoms appear, and the disease progresses rapidly. The opportunity for surgical treatment may have been missed, and only systemic chemotherapy or other comprehensive treatments are available to alleviate symptoms.